Jaguar Health’s Napo Pharmaceuticals and Napo Therapeutics announced that preliminary results from the ongoing pediatric investigator-initiated trial of a novel liquid formulati ...

Crofelemer, a novel plant-based anti-secretory prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines ...